Taliglucerase Alfa Injection
Learn more about Elsevier’s Drug Patient Education today! Empower and engage your patients to use medication safely.
Taliglucerase alfa (tal i GLOO ser ace alfa) is a man-made form of an enzyme that is missing in patients with Gaucher's disease. It is used to treat the symptoms of Gaucher's disease. It is not a cure.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
This medicine is for infusion into a vein. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.NOTE: This medicine is only for you. Do not share this medicine with others.
Side effects that you should report to your doctor or health care professional as soon as possible:
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
This drug is given in a hospital or clinic and will not be stored at home.
They need to know if you have any of these conditions:
Interactions are not expected.
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Visit your doctor for regular checks on your progress. Tell your doctor or healthcare professional if your symptoms do not start to get better or if they get worse.
Cookies are used by this site. To decline or learn more, visit our cookie notice.